EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms

Overview of attention for article published in Nanotechnology Science and Applications, July 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,854 followers.

EGF receptor-targeting cancer therapy using CD47 https://t.co/DmbQkOyN6Q

New article: EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms https://t.co/7UGkGJVYj8 #kidneycancer #oncology https://t.co/wFw1xEUadv

EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms https://t.co/yWk7FEfItp

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.